
July 05, 2024
Hygrovest Limited (ASX:HGV) ("HGV") is an Australian-listed specialist investment company which concentrates on producing capital growth for shareholders over the medium to long term from investments in listed and unlisted equities and other financial assets.
HGV encloses the Appendix 4D and financial statements in respect of the half year ended 31 December 2021 lodged in accordance with ASX LR4.2B.
Hygrovest Limited Appendix 4D
Half-Year Report
- Company details
Name of entity:
Hygrovest Limited (formerly known as MMJ Group Holdings Limited)1
ABN: 91 601 236 417
Reporting period:
For the half-year ended 31 December 2021 (the Current Financial Period) and 31 December 2020
Revenues from ordinary activities | up | 93% | 31-Dec-21 000 (5,590) | 31-Dec-20 000 (2,894) |
Loss from ordinary activities after tax attributable to the | ||||
owners of Hygrovest Limited | up | 142% | (5,288) | (2,188) |
Loss for the half-year attributable to the owners of Hygrovest | ||||
Limited | up | 142% | (5,288) | (2,188) |
Click here for the full ASX Release
This article includes content from Hygrovest Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
HGV:AU
The Conversation (0)
12 January 2022
Hygrovest Limited
Building a globally diversified portfolio of companies in high-growth industries.
19 September
Cannabis Crossroads: Record US Demand Meets Federal Gridlock
The US cannabis industry is at a turning point. State-level legalization and retail growth continue to accelerate, but federal policy remains stalled, leaving businesses navigating both opportunity and uncertainty. Record consumer demand is driving sales, yet outdated regulations, restrictive... Keep Reading...
22 July
10 Biggest Cannabis Stocks in the US and Canada in 2025
After initial optimism for rescheduling in the US, the cannabis market has faced challenges in 2025. Despite signs of support from US President Donald Trump and members of his administration, regulatory uncertainty persists in the US. Companies are shifting focus to match changes in consumer... Keep Reading...
17 July
Cannabis Market Update: H1 2025 in Review
The first half of 2025 played out differently than many cannabis market participants expected. Heading into the year, there was optimism that rescheduling in the US would reduce or eliminate challenges, but the industry continued to grapple with persistent federal regulatory uncertainty,... Keep Reading...
25 June
Thailand Reverses Course on Cannabis, Moves to Recriminalize Amid Political Fallout
Thailand’s groundbreaking experiment with cannabis decriminalization is rapidly unraveling, with the government formally moving to reclassify the plant as a narcotic and ban recreational sales.The decision has sent shockwaves through an industry once projected to be worth over US$1 billion.The... Keep Reading...
09 May
A State-by-State Guide to Cannabis in Australia
Australia federally legalised medicinal cannabis in 2016, and Australia's cannabis market has seen major growth since then.Medical cannabis approvals were up by 120 percent in the first half of 2023 compared to the same period in 2022. Statista forecasts that Australian cannabis revenue will... Keep Reading...
01 May
New Cannabis Consumption Trends, Regulatory Shifts Seen Driving Market in 2025
Understanding trends in the cannabis industry is paramount for investors eyeing a market with steady growth potential, but the landscape is complex as products and regulations continue to evolve. Consumption habits are changing as edibles, vaping and THC beverages gain traction, especially among... Keep Reading...
Latest News
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00